PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 87 filers reported holding PMV PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,668 | -78.7% | 39,034 | -83.4% | 0.00% | – |
| Q1 2023 | $1,123,082 | +78.0% | 235,447 | +224.7% | 0.00% | – |
| Q4 2022 | $630,924 | +121.4% | 72,520 | +203.1% | 0.00% | – |
| Q3 2022 | $285,000 | -19.9% | 23,927 | -4.2% | 0.00% | – |
| Q2 2022 | $356,000 | -45.2% | 24,975 | -20.0% | 0.00% | – |
| Q1 2022 | $650,000 | -54.7% | 31,200 | -25.7% | 0.00% | -100.0% |
| Q2 2021 | $1,435,000 | +28.9% | 42,000 | +34.0% | 0.00% | 0.0% |
| Q3 2020 | $1,113,000 | – | 31,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |